Conference
Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)—An Interim Analysis
Authors
Schuster S; Bishop MR; Tam C; Waller EK; Borchmann P; McGuirk J; Jäger U; Jaglowski S; Andreadis C; Westin J
Volume
17
Pagination
pp. s373-s374
Publisher
Elsevier
Publication Date
September 2017
DOI
10.1016/j.clml.2017.07.213
Conference proceedings
Clinical Lymphoma Myeloma & Leukemia
ISSN
2152-2650